RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

This compilation of regulatory terms and definitions was originally derived from a set of RAPS publications covering the US, EU, Canada and international markets. It includes more than 2,000 definitions from a variety of sources, specifying the region for each, cross-referenced for easy use. Entries were selected based on their relevance to professionals involved in all lifecycle stages for biologics, medicinal products, medical devices and related healthcare products.  This resource is intended for regulatory professionals, developed by regulatory professionals, and RAPS members are encouraged to share input, make additions, or otherwise provide clarity where it might benefit fellow regulatory pros.

This Acronyms & Definitions resource is only available to RAPS members. Please log in to your account. If you are not a member, then join today!

Help us build Regipedia!  RAPS members may suggest ADDITIONS or EDITS of terms and definitions. Submissions will be vetted by RAPS editorial review team, and notification of approval or denial will be made within 48 business hours.